Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 681

1.

Cross-presentation: underlying mechanisms and role in immune surveillance.

Rock KL, Shen L.

Immunol Rev. 2005 Oct;207:166-83. Review.

PMID:
16181335
2.

Priming of T cells by exogenous antigen cross-presented on MHC class I molecules.

Shen L, Rock KL.

Curr Opin Immunol. 2006 Feb;18(1):85-91. Epub 2005 Dec 2. Review.

PMID:
16326087
3.

The cross-priming pathway: a portrait of an intricate immune system.

Basta S, Alatery A.

Scand J Immunol. 2007 Apr;65(4):311-9. Review.

4.

Mechanisms of MHC class I-restricted antigen processing and cross-presentation.

Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA.

Immunol Rev. 2005 Oct;207:145-57. Review.

PMID:
16181333
5.

Class I MHC presentation of exogenous antigens.

Harding CV.

J Clin Immunol. 1996 Mar;16(2):90-6. Review.

PMID:
8690777
6.

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.

Sigal LJ, Crotty S, Andino R, Rock KL.

Nature. 1999 Mar 4;398(6722):77-80.

PMID:
10078533
7.

Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes.

Reimann J, Böhm W, Schirmbeck R.

Biol Chem Hoppe Seyler. 1994 Nov;375(11):731-6. Review.

PMID:
7535058
8.

Immune selection in murine tumors. Ph.d thesis.

Svane IM, Engel AM.

APMIS Suppl. 2003;(106):1-46.

PMID:
12739251
9.

Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway.

Kurotaki T, Tamura Y, Ueda G, Oura J, Kutomi G, Hirohashi Y, Sahara H, Torigoe T, Hiratsuka H, Sunakawa H, Hirata K, Sato N.

J Immunol. 2007 Aug 1;179(3):1803-13.

10.

Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties.

François M, Romieu-Mourez R, Stock-Martineau S, Boivin MN, Bramson JL, Galipeau J.

Blood. 2009 Sep 24;114(13):2632-8. doi: 10.1182/blood-2009-02-207795. Epub 2009 Aug 4.

11.

Toward a molecular explanation for cross-presentation of antigens to the immune system.

Khor B, Makar RS.

Transfus Med Rev. 2008 Jul;22(3):188-201. doi: 10.1016/j.tmrv.2008.02.002. Review.

PMID:
18572095
12.

[Molecular basis for detection of infectious agents].

Siegrist CA.

Schweiz Med Wochenschr. 1996 Feb 17;126(7):246-54. French.

PMID:
8720322
14.

A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.

Segura E, Villadangos JA.

Traffic. 2011 Dec;12(12):1677-85. doi: 10.1111/j.1600-0854.2011.01254.x. Epub 2011 Aug 16. Review.

16.

Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation.

Burgdorf S, Schölz C, Kautz A, Tampé R, Kurts C.

Nat Immunol. 2008 May;9(5):558-66. doi: 10.1038/ni.1601. Epub 2008 Mar 30.

PMID:
18376402
17.

Cross-presentation in viral immunity and self-tolerance.

Heath WR, Carbone FR.

Nat Rev Immunol. 2001 Nov;1(2):126-34. Review.

PMID:
11905820
18.

Cross-presentation of antigens by dendritic cells.

Belz GT, Carbone FR, Heath WR.

Crit Rev Immunol. 2002;22(5-6):439-48. Review.

PMID:
12803320
19.

[Processing of MHC class I presented antigens].

van Endert P.

Med Sci (Paris). 2006 Aug-Sep;22(8-9):727-32. Review. French.

20.

Class II MHC molecules can use the endogenous pathway of antigen presentation.

Nuchtern JG, Biddison WE, Klausner RD.

Nature. 1990 Jan 4;343(6253):74-6.

PMID:
1967486

Supplemental Content

Support Center